Spectral interactions of tetrachlorobiphenyls with hepatic microsomal cytochrome P450 enzymes

Chemico-Biological Interactions

Volumn 146, Issue 3, 2003, Pages 285-296

  Hrycay, Eugene G ^a   Bandiera, Stelvio M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cytochrome P450; Tetrachlorobiphenyls; Type I spectral binding

Indexed keywords

2,2',4,4' TETRACHLOROBIPHENYL; 2,2',5,5' TETRACHLOROBIPHENYL; 3 METHYLCHOLANTHRENE; 3,3',4,4' TETRACHLOROBIPHENYL; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 2B; CYTOCHROME P450 2C; CYTOCHROME P450 3A; DEXAMETHASONE; PHENOBARBITAL; TETRACHLOROBIPHENYL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CHLORINATION; CONTROLLED STUDY; ENZYME BINDING; ENZYME SPECIFICITY; FEMALE; LIVER MICROSOME; MALE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0344442736     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2003.09.003     Document Type: Article

References (50)

1. Schenkman J.B., Remmer H., Estabrook R.W. Spectral studies of drug interaction with hepatic microsomal cytochrome. Mol. Pharmacol. 3:1967;113-123.
2. Schenkman J.B., Frey I., Remmer H., Estabrook R.W. Sex differences in drug metabolism by rat liver microsomes. Mol. Pharmacol. 3:1967;516-525.
3. Hrycay E.G., Gustafsson J-Å., Ingelman-Sundberg M., Ernster L. The involvement of cytochrome P-450 in hepatic microsomal steroid hydroxylation reactions supported by sodium periodate, sodium chlorite, and organic hydroperoxides. Eur. J. Biochem. 61:1976;43-52.
4. Ebel R.E., O'Keeffe D.H., Peterson J.A. Substrate binding to hepatic microsomal cytochrome P-450. J. Biol. Chem. 253:1978;3888-3897.
5. Ebel R.E. In vitro effects of chlordecone (kepone) on hepatic microsomal cytochrome P- 450. Pestic. Biochem. Physiol. 14:1980;221-226.
6. Schenkman J.B., Sligar S.G., Cinti D.L. Substrate interaction with cytochrome P-450. Pharmacol. Ther. 12:1981;43-71.
7. Burke M.D., Bridges J.W. Biphenyl hydroxylations and spectrally apparent interactions with liver microsomes from hamsters pre-treated with phenobarbitone and 3- methylcholanthrene. Xenobiotica. 5:1975;357-376.
8. Hutzler J.M., Wienkers L.C., Wahlstrom J.L., Carlson T.J., Tracy T.S. Activation of cytochrome P450 2C9-mediated metabolism: mechanistic evidence in support of kinetic observations. Arch. Biochem. Biophys. 410:2003;16-24.
9. Hutzler J.M., Walker G.S., Wienkers L.C. Inhibition of cytochrome P450 2D6: structure-activity studies using a series of quinidine and quinine analogues. Chem. Res. Toxicol. 16:2003;450-459.
10. Vatsis K.P., Coon M.J. Ipso-substitution by cytochrome P450 with conversion of p- hydroxybenzene derivatives to hydroquinone: evidence for hydroperoxo-iron as the active oxygen species. Arch. Biochem. Biophys. 397:2002;119-129.
11. Safe S. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit. Rev. Toxicol. 24:1994;87-149.
12. Hansen L.G. Stepping backward to improve assessment of PCB congener toxicities. Environ. Health Perspect. 106:1998;171-189.
13. S.M. Bandiera, Cytochrome P450 enzymes as biomarkers of PCB exposure and modulators of toxicity, in: L.W. Robertson, L.G. Hansen (Eds.), PCBs: Recent Advances in Environmental Toxicology and Health Effects, University Press of Kentucky, Lexington, 2001, pp. 185-192.
14. Mathews H.B., Anderson M.W. Effect of chlorination on the distribution and excretion of polychlorinated biphenyls. Drug. Metab. Dispos. 3:1975;371-380.
15. Kato S., McKinney J.D., Mathews H.B. Metabolism of symmetrical hexachlorobiphenyl isomers in the rat. Toxicol. Appl. Pharmacol. 53:1980;389-398.
16. Kaminsky L.S., Kennedy M.W., Adams S.M., Guengerich F.P. Metabolism of dichlorobiphenyls by highly purified isozymes of rat liver cytochrome P450. Biochemistry. 20:1981;7379-7384.
17. Preston D.B., Miller J.A., Miller E.C. Non-arene oxide aromatic ring hydroxylation of 2,2′,5,5′-tetrachlorobiphenyl as the major metabolic pathway catalyzed by phenobarbital-induced rat liver microsomes. J. Biol. Chem. 258:1983;8304-8311.
18. Mills R.A., Millis C.D., Dannan G.A., Guengerich F.P., Aust S.D. Studies on the structure-activity relationships for the metabolism of polybrominated biphenyls by rat liver microsomes. Toxicol. Appl. Pharmacol. 78:1985;96-104.
19. Schnellmann R.G., Vickers A.E.M., Sipes G. Metabolism and disposition of polychlorinated biphenyls. Rev. Biochem. Toxicol. 7:1985;247-282.
20. Borlakoglu J.T., Wilkins J.P.G. Metabolism of di-, tri,- tetra-, penta- and hexachlorobiphenyls by hepatic microsomes isolated from control animals and animals treated with Aroclor 1254, a commercial mixture of polychlorinated biphenyls (PCBs). Comp. Biochem. Physiol. 105:1993;95-106.
21. Haraguchi K., Kato Y., Kimura R., Masuda Y. Comparative study on formation of hydroxyl and sulfur-containing metabolites from different chlorinated biphenyls with 2,5- substitution in rats. Drug Metab. Dispos. 25:1997;845-852.
22. DeVoss J.J., Sibbesen O., Zhang Z., Ortiz de Montellano P.R. Substrate docking algorithms and prediction of the substrate specificity of cytochrome P450cam and its L244A mutant. J. Am. Chem. Soc. 119:1997;5480-5498.
23. D.F.V. Lewis, Cytochromes P450: Structure, Function and Mechanism, Taylor and Francis, London, 1996.
24. ® on hepatic expression of cytochrome P450 2B in the rat. Biochem. Pharmacol. 52:1996;735-742.
25. Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239:1964;2370-2378.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
27. Murray M., Reidy G.F. In vitro inhibition of hepatic drug oxidation by thioridazine. Biochem. Pharmacol. 38:1989;4359-4365.
28. Bandiera S., Dworschak C. Effects of testosterone and estrogen on hepatic levels of cytochromes P450 2C7 and P450 2C11 in the rat. Arch. Biochem. Biophys. 296:1992;286-295.
29. Lin S., Bullock P.L., Addison R.F., Bandiera S.M. Detection of cytochrome P4501A in several species using antibody against a synthetic peptide derived from rainbow trout cytochrome P4501A1. Environ. Toxicol. Chem. 17:1998;439-445.
30. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedures and some applications. Proc. Natl. Acad. Sci. U.S.A. 76:1979;4350-4354.
31. Ryan D.E., Levin W. Purification and characterization of hepatic microsomal cytochrome P450. Pharmacol. Ther. 45:1990;153-239.
32. J.B. Schenkman, H. Griem (Eds.), Cytochrome P450, Handbook of Experimental Pharmacology, vol. 105, Springer-Verlag, Berlin, 1993.
33. Diliberto J.J., Burgin D.E., Birnbaum L.S. Effects of CYP1A2 on disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,4,7,8- pentachlorodibenzofuran, and 2,2′,4,4′,5,5′- hexachlorobiphenyl in CYP1A2 knockout and parental (C57BL/6N and 129/Sv) strains of mice. Toxicol. Appl. Pharmacol. 159:1999;52-64.
34. Ishida C., Koga N., Hanioka N., Saeki H.K., Yoshimura H. Metabolism in vitro of 3,4,3′,4′- and 2,5,2′,5′-tetrachlorobiphenyl by rat liver microsomes and highly purified cytochrome P-450. J. Pharmacobio-Dyn. 14:1991;276-284.
35. 5 in the metabolism of tetrachlorobiphenyls catalyzed by CYP2B1 and CYP1A1. Chemosphere. 32:1996;517-523.
36. Blanck J., Rein H., Sommer M., Ristau O., Smettan G., Ruckpaul K. Correlations between spin equilibrium shift, reduction rate, and N-demethylation activity in liver microsomal cytochrome P-450 and a series of benzphetamine analogues as substrates. Biochem. Pharmacol. 32:1984;1683-1688.
37. Tamburini P.P., Gibson G.G., Backes W.L., Sligar S.G., Schenkman J.B. Reduction kinetics of purified rat liver cytochrome P-450. Evidence for a sequential reaction mechanism dependent on the hemoprotein spin state. Biochemistry. 23:1984;4526-4533.
38. Black S.D., Coon M.J. P-450 cytochromes: structure and function. Adv. Enzymol. Relat. Areas Mol. Biol. 60:1987;35-87.
39. Al-Gailany K.A.S., Houston J.B., Bridges J.W. The role of substrate lipophilicity in determining type I microsomal P450 binding characteristics. Biochem. Pharmacol. 27:1978;783-788.
40. Jansson I., Orrenius S., Ernster L., Schenkman J.B. A study of the interaction of a series of substituted barbituric acids with the hepatic microsomal monooxygenase. Arch. Biochem. Biophys. 151:1972;391-400.
41. Fischer L.J., Seegal R.F., Ganey P.E., Pessah I.N., Kodavanti P.R.S. Symposium review: toxicity of non-coplanar PCBs. Toxicol. Sci. 41:1998;49-61.
42. Höfler F., Melzer H., Möckel H.J., Robertson L.W., Anklam E. Relationship between liquid and gas chromatographic retention behavior and calculated molecular surface area of selected polyhalogenated biphenyls. J. Agric. Food Chem. 36:1988;961-965.
43. Duignan D.B., Sipes I.G., Leonard T.B., Halpert J.R. Purification and characterization of the dog hepatic cytochrome P-450 isozyme responsible for the metabolism of 2,2′,4,4′,5,5′- hexachlorobiphenyl. Arch. Biochem. Biophys. 255:1987;290-303.
44. Duignan D.B., Sipes I.G., Ciaccio P.J., Halpert J.R. The metabolism of xenobiotics and endogenous compounds by the constitutive dog liver cytochrome P450 PBD-2. Arch. Biochem. Biophys. 267:1988;106-115.
45. Parkinson A., Safe S.H., Robertson L.W., Thomas P.E., Ryan D.E., Reik L.M., Levin W. Immunochemical quantitation of cytochrome P-450 isozymes and epoxide hydrolase in liver microsomes from polychlorinated or polybrominated biphenyl-treated rats. J. Biol. Chem. 258:1983;5967-5976.
46. Connor K., Safe S., Jefcoate C.R., Larsen M. Structure-dependent induction of CYP2B by polychlorinated biphenyl congeners in female Sprague-Dawley rats. Biochem. Pharmacol. 50:1995;1913-1920.
47. Cooper K.O., Reik L.M., Jayyosi Z., Bandiera S., Kelley M., Ryan D.E., Daniel R., McCluskey S.A., Levin W., Thomas P.E. Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Arch. Biochem. Biophys. 301:1993;345-354.
48. Schuetz E.G., Wrighton S.A., Safe S.H., Guzelian P.S. Regulation of cytochrome P-450p by phenobarbital and phenobarbital-like inducers in adult rat hepatocytes in primary monolayer culture and in vivo. Biochemistry. 25:1986;1124-1133.
49. Schuetz E.G., Brimer C., Schuetz J.D. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element. Mol. Pharmacol. 54:1998;1113-1117.
50. C. Hansch, A. Leo, D. Hoekman, Exploring QSAR: Hydrophobic, Electronic, and Steric Constants, American Chemical Society, Washington, DC, 1995.